Error loading player: No playable sources found
Workshop II: Microbial In-Use Studies and Closed System Transfer Devices
Date
January 22, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers:
In-Use Studies Microbial Challenge Studies: Cross-Industry Efforts to Harmonize Strategies in Collaboration with Health Authorities
J. Paul Kirwan, Amgen Inc.
Pharmaceutical Industry Perspective on Closed System Transfer Devices (CSTDs): Balancing Overfill, Evaluating, Communicating
Christian Lehermayr, Novartis Pharma AG
Additional Panelists:
Virginia Carroll, CDER, FDA
Nicholas Clark, Amgen Inc.
John Metcalfe, CDER, FDA
Related Products
Workshop IV: Emerging Trends in Compatibility and In-Use Stability Studies & Closing Remarks
IN-USE COMPATIBILITY TESTING OF CELL AND GENE THERAPIES (CGT)
CASSS Welcome and CMC Strategy Forum 2024 Introductory Comments
Platform technologies are used extensively across the biopharmaceutical industry to develop drugs efficiently and effectively. The application of prior knowledge and platforms from established products lays a strong foundation to guide development and advance new medicines to the patients…
Workshop III: Product In-Use: Meeting Patient and User Needs
PATIENT AND USER-CENTRIC CONSIDERATIONS ON IN-USE STUDY DESIGN
Workshop II: Process
INCORPORATION OF PLATFORM BASED APPROACHES AND PRIOR KNOWLEDGE LEVERAGING INTO THE RECENTLY REVISED ICH Q5A (R2) GUIDELINE
